doi: 10.1002/1097-0142(197307)32:1<18::aid-cncr2820320103>3.0.co;2-q.
Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance
- PMID: 4577503
- DOI: 10.1002/1097-0142(197307)32:1<18::aid-cncr2820320103>3.0.co;2-q
Item in Clipboard
Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance
Cancer.
1973 Jul.
No abstract available
Similar articles
-
Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.Acta Derm Venereol. 1979;59(1):64-8. Acta Derm Venereol. 1979. PMID: 84470
-
Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.Dermatologica. 1978;156(3):129-41. Dermatologica. 1978. PMID: 342293 Clinical Trial.
-
Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.Ann Intern Med. 1967 Aug;67(2):282-90. doi: 10.7326/0003-4819-67-2-282. Ann Intern Med. 1967. PMID: 6036390 No abstract available.
-
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29440874 Free PMC article. Review.
-
Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.Int J Dermatol. 1984 Apr;23(3):180-6. doi: 10.1111/j.1365-4362.1984.tb04507.x. Int J Dermatol. 1984. PMID: 6373639 Review. No abstract available.
Cited by
-
Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel.Cancer Manag Res. 2019 Mar 20;11:2241-2251. doi: 10.2147/CMAR.S138661. eCollection 2019. Cancer Manag Res. 2019. PMID: 30962713 Free PMC article. Review.
-
Weekly total skin electron beam therapy for mycosis fungoides and other cutaneous lymphomata: further experience.Br J Cancer Suppl. 1975 Mar;2:379-85. Br J Cancer Suppl. 1975. PMID: 810154 Free PMC article.
-
The treatment of mycosis fungoides and related conditions with particular emphasis on electron therapy.Br J Cancer Suppl. 1975 Mar;2:368-78. Br J Cancer Suppl. 1975. PMID: 810153 Free PMC article.
-
New concepts in the management of mycosis fungoides.West J Med. 1974 Feb;120(2):150-1. West J Med. 1974. PMID: 18747333 Free PMC article. No abstract available.
-
Hypersensitivity reactions from antineoplastic agents.Cancer Metastasis Rev. 1987;6(3):413-32. doi: 10.1007/BF00144273. Cancer Metastasis Rev. 1987. PMID: 3319275 Review.